Received Nov 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
been ragingly flaring ever since; This non-serious case was reported by a consumer via call center representative and described the occurrence of herpes zoster in a 50-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concurrent medical conditions included psoriasis. On 04-SEP-2025, the patient received the 1st dose of Shingles vaccine. The patient experienced herpes zoster (Verbatim: been ragingly flaring ever since). The outcome of the herpes zoster was not resolved. It was unknown if the reporter considered the herpes zoster to be related to Shingles vaccine. It was unknown if the company considered the herpes zoster to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 19-NOV-2025 The reporter mentioned that the patient had been ragingly flaring ever since. The patient enquired whether to take second or to wait until the flaring lower down. The batch number was not provided and a request for this information has been made.
Psoriasis